Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Concert Pharmaceuticals, Inc. - Common Stock (NQ:CNCE)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Mar 3, 2023 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	-
Bid (Size)	8.300 (1)
Ask (Size)	9.000 (6)
Prev. Close	8.370
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	32,173,778
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Concert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia Areata

February 15, 2023

From Concert Pharmaceuticals, Inc.

Via Business Wire

CNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders

February 13, 2023

From Halper Sadeh LLC

Via Business Wire

Performance

More News

Why Concert Pharmaceuticals Stock Rocketed Higher This Week ↗

January 20, 2023

Via The Motley Fool

CONCERT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Concert Pharmaceuticals, Inc. - CNCE

January 20, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

India-Based Sun Pharma Scoops Up Concert Pharmaceuticals For $576M Plus Milestones ↗

January 19, 2023

Via Benzinga

Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 19, 2023

Via Benzinga

Concert Pharmaceuticals, Coeur Mining And Other Big Stocks Moving Higher On Thursday ↗

January 19, 2023

Via Benzinga

Concert Pharmaceuticals's Return On Capital Employed Insights ↗

November 29, 2022

Via Benzinga

Concert Pharma: Q3 Earnings Insights ↗

November 07, 2022

Via Benzinga

Dow Falls 200 Points; Jobless Claims Drop To 4-Month Low ↗

January 19, 2023

Via Benzinga

CNCE Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders

January 19, 2023

From Halper Sadeh LLC

Via Business Wire

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata

January 19, 2023

From Concert Pharmaceuticals

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 18, 2023

Via Benzinga

Is Ardelyx is A Buy After Slip in Early 2022

November 21, 2022

Via MarketBeat

Concert Pharmaceuticals Announces Presentation of Deuruxolitinib THRIVE-AA1 Phase 3 Study Results in Alopecia Areata During World Congress for Hair Research

November 21, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

Concert Pharmaceuticals to Participate in Fireside Chat at the Jefferies London Healthcare Conference

November 09, 2022

From Concert Pharmaceuticals

Via Business Wire

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗

November 08, 2022

Via Benzinga

Concert Pharmaceuticals Reports Third Quarter 2022 Financial Results

November 07, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

Concert Pharmaceuticals to Report Third Quarter 2022 Results on November 7, 2022

October 31, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

Planet Labs, Core & Main And Some Other Big Stocks Moving Higher On Tuesday ↗

September 13, 2022

Via Benzinga

Concert Pharmaceuticals Announces Presentation of CTP-543 THRIVE-AA1 Phase 3 Data in Alopecia Areata During Late Breaking Session at EADV Congress

September 10, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

Concert Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference

September 06, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

Bridges and Landmarks Across the USA Will Illuminate Blue Throughout the Month of September for Alopecia Areata

September 01, 2022

From Concert Pharmaceuticals, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Via Benzinga

Frequently Asked Questions

Is Concert Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Concert Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Concert Pharmaceuticals, Inc. - Common Stock trade on?

Concert Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Concert Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Concert Pharmaceuticals, Inc. - Common Stock is CNCE on the Nasdaq Stock Market

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.